Showing 3821-3830 of 6035 results for "".
- Alcon Acquires Fluid-Based IOL Maker PowerVisionhttps://modernod.com/news/alcon-announces-acquisition-of-powervision/2476387/Alcon announced that it has acquired PowerVision for $285 million plus regulatory and milestone payments starting in 2023. PowerVision’s lens design utilizes the eye’s natural accommodating response to transport fluid in the IOL. While most presbyopia-correcting IOLs use a mult
- Coburn Technologies Introduces New Spin Coater with Dual-Coating Technology, Velocity 2Dhttps://modernod.com/news/coburn-technologies-introduces-new-spin-coater-with-dual-coating-technology-velocity-2d/2476376/Coburn Technologies has introcued the Velocity 2D, the next generation of the Velocity Automated Spin Coater, now designed with dual-coating technology. Derived from the existing platform of the ground-breaking Velocity automated lens coater, the Velocity 2D now offers labs the ability to
- Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington Universityhttps://modernod.com/news/q-biomed-licenses-novel-biomarker-for-monitoring-glaucoma-severity-and-progression-from-washington-university/2476369/Q BioMed has announced it has exercised its option to exclusively license GDF15, a diagnostic marker for determining the severity of glaucoma using the expression levels of Growth Differentiation Factor 15 (GDF15) from the Washington University in St. Louis. Determining the severity
- Roche/Genentech Study Shows First-Time Proof That AI Can Detect Severity of DMEhttps://modernod.com/news/roche-genentech-study-shows-first-time-proof-that-ai-can-detect-severity-of-dme/2476347/A new study published in the journal
- Macula May Not Benefit From a Blue-Light Filtering Intraocular Lenshttps://modernod.com/news/macula-may-not-benefit-from-a-blue-light-filtering-intraocular-lens/2476346/Inserting a blue light-filtering IOL during cataract surgery may not benefit the macula, researchers say, according to a Reuters report. “It has been suggested that IOLs that selectively attenuate short wavelength visible l
- Roche Acquires Spark Therapeutics in $4.8 Billion Dealhttps://modernod.com/news/roche-acquires-spark-therapeutics-in-4-3-billion-deal/2476268/Swiss pharma giant Roche acquired and Philadelphia-based gene therapy company Spark Therapeutics in an all cash transaction worth $4.8 billion, or $114.50 per share. The merger has been unanimously approved by the boards of Spark Therap
- Bausch Health Reduces Debt By Additional $100 Millionhttps://modernod.com/news/bausch-health-reduces-debt-by-additional-100-million/2476341/Bausch Health Companies, the parent company of Bausch + Lomb, announced it has paid down an additional $100 million of its senior secured term loans using cash generated from operations. “As Bausch Health pivots to offense in 2019, we continue to remain
- Study: Scleral Lenses Coated with Tangible Hydra-PEG Improve Dry Eye Symptoms, Comforthttps://modernod.com/news/study-scleral-lenses-coated-with-tangible-hydra-peg-improve-dry-eye-symptoms-comfort/2476344/Tangible Science announced that a
- Nicox Establishes High-Profile Glaucoma Clinical Advisory Boardhttps://modernod.com/news/nicox-establishes-high-profile-glaucoma-clinical-advisory-board/2479601/Nicox SA announced the formation of Nicox Glaucoma Clinical Advisory Board, composed of key clinical investigators and opinion leaders in the field, to support and guide the development of its innovative NO-donating compounds as potential IOP-lowering drugs.
- Cultivating 4-D Tissues: The Self-Curving Corneahttps://modernod.com/news/cultivating-4-d-tissues-the-self-curving-cornea/2476176/Scientists at Newcastle University have developed a biological system which lets cells form a desired shape by moulding their surrounding material—in the first instance creating a self-curving cornea. In the research, a flat circle of gel containing corneal stromal cells (stem